04:33 PM EDT, 04/04/2025 (MT Newswires) -- Blackstone (BX) and Carlyle (CG)-backed Medline has postponed its planned initial public offering amid market volatility tied to US President Donald Trump's import tariffs, The Financial Times reported Friday, citing people familiar with the matter.

Medtech company Medline was targeting a valuation close to $50 billion and had planned to file its listing paperwork this week, the FT reported.

Virtual physical therapy provider Hinge Health, which filed its paperwork last month, has also delayed its investor roadshow amid unsettled market conditions, sources reportedly said.

Medline, Hinge Health, Blackstone and Carlyle did not immediately respond to requests for a comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)